Potential Allergens in Wine: Double-Blind Placebo-Controlled Trial
This study is designed to identify whether wines which are produced using the common potential food allergens such as proteins derived from fish, milk or egg are likely to contain sufficient food allergens to cause allergic reactions in susceptible individuals.
Official Title
Potential Allergens in Wine: Double Blind Placebo-Controlled Trial and Basophil Activation Analysis
Conditions
- Food Allergy
- Anaphylaxis
Study Type
Interventional
Study Design
Diagnostic, Randomised, Double-Blind, Placebo Control, Crossover Assignment, Safety Study
Further Details
Primary Outcome Measures:
- Allergic reactions to wine
Secondary Outcome Measures:
- Positive basophil activation test to wines
Study Start
August 2002
Eligibility & Criteria
Official Title
Potential Allergens in Wine: Double Blind Placebo-Controlled Trial and Basophil Activation Analysis
Conditions
- Food Allergy
- Anaphylaxis
Study Type
Interventional
Study Design
Diagnostic, Randomised, Double-Blind, Placebo Control, Crossover Assignment, Safety Study
Further Details
Primary Outcome Measures:
- Allergic reactions to wine
Secondary Outcome Measures:
- Positive basophil activation test to wines
Study Start
August 2002
Eligibility & Criteria
Eligibility
- Ages Eligible for Study: 18 Years to 65 Years
- Genders Eligible for Study: Both
- Accepts Healthy Volunteers: Yes
Criteria
Inclusion Criteria:
- Individuals with IgE-mediated food allergy to milk, fish, egg or nuts Otherwise no major medical problems Able to drink wine –
Exclusion Criteria:
- Major asthma or cardiac disease Unwilling or unable to participate
Total Enrolment
40
Contact Details
Please refer to this study by its ClinicalTrials.gov identifier: NCT00163735
Contacts
Contact: Robyn E O’Hehir, MBBS FRACP PhD ++613 9276 2251 r.ohehir@alfred.org.au
Locations
Australia, Victoria
AIR Med, Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3004
Contact: Robyn E OHehir, MBBS PhD FRACP ++6139276 2251 r.ohehir@alfred.org.au
Principal Investigator: Robyn E O’Hehir, MBBS FRACP PhD
Sponsors and Collaborators
Bayside Health
The Australian Wine Research Institute, Adelaide
National Health and Medical Research Council, Australia
The Alfred
Investigators
Study Director: Robyn E O’Hehir, MBBS PhD FRACP Alfred Hospital and Monash University
Principal Investigator: Jennifer M Rolland, PhD Monash University
Principal Investigator: Creina S Stockley, PhD The Australian Wine Research Institute
Total Enrolment
40
Contact Details
Please refer to this study by its ClinicalTrials.gov identifier: NCT00163735
Contacts
Contact: Robyn E O’Hehir, MBBS FRACP PhD ++613 9276 2251 r.ohehir@alfred.org.au
Locations
Australia, Victoria
AIR Med, Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3004
Contact: Robyn E OHehir, MBBS PhD FRACP ++6139276 2251 r.ohehir@alfred.org.au
Principal Investigator: Robyn E O’Hehir, MBBS FRACP PhD
Sponsors and Collaborators
Bayside Health
The Australian Wine Research Institute, Adelaide
National Health and Medical Research Council, Australia
The Alfred
Investigators
Study Director: Robyn E O’Hehir, MBBS PhD FRACP Alfred Hospital and Monash University
Principal Investigator: Jennifer M Rolland, PhD Monash University
Principal Investigator: Creina S Stockley, PhD The Australian Wine Research Institute
Dates
Tags
Created by: